Annual total expenses:
$2.43B+$314.66M(+14.91%)Summary
- As of today (August 25, 2025), ALNY annual total expenses is $2.43 billion, with the most recent change of +$314.66 million (+14.91%) on December 31, 2024.
- During the last 3 years, ALNY annual total expenses has risen by +$872.19 million (+56.16%).
- ALNY annual total expenses is now at all-time high.
Performance
ALNY Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$839.97M+$188.30M(+28.89%)Summary
- As of today (August 25, 2025), ALNY quarterly total expenses is $839.97 million, with the most recent change of +$188.30 million (+28.89%) on June 30, 2025.
- Over the past year, ALNY quarterly total expenses has increased by +$163.25 million (+24.12%).
- ALNY quarterly total expenses is now at all-time high.
Performance
ALNY Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ALNY Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.9% | +24.1% |
| 3 y3 years | +56.2% | +67.3% |
| 5 y5 years | +109.2% | +196.6% |
ALNY Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.2% | at high | +70.2% |
| 5 y | 5-year | at high | +109.2% | at high | +196.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ALNY Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $839.97M(+28.9%) |
| Mar 2025 | - | $651.67M(-3.7%) |
| Dec 2024 | $2.43B(+14.9%) | $676.93M(+10.5%) |
| Sep 2024 | - | $612.49M(-9.5%) |
| Jun 2024 | - | $676.71M(+20.8%) |
| Mar 2024 | - | $560.27M(-3.0%) |
| Dec 2023 | $2.11B(+15.8%) | $577.59M(-4.2%) |
| Sep 2023 | - | $602.78M(+1.3%) |
| Jun 2023 | - | $594.78M(+20.5%) |
| Mar 2023 | - | $493.39M(-9.1%) |
| Dec 2022 | $1.82B(+17.4%) | $542.53M(-19.1%) |
| Sep 2022 | - | $670.23M(+33.5%) |
| Jun 2022 | - | $502.22M(+10.7%) |
| Mar 2022 | - | $453.60M(-12.3%) |
| Dec 2021 | $1.55B(+17.5%) | $517.00M(+31.8%) |
| Sep 2021 | - | $392.15M(-4.4%) |
| Jun 2021 | - | $410.11M(+8.5%) |
| Mar 2021 | - | $377.86M(-7.2%) |
| Dec 2020 | $1.32B(+14.0%) | $407.10M(+7.4%) |
| Sep 2020 | - | $379.14M(+33.9%) |
| Jun 2020 | - | $283.19M(+0.5%) |
| Mar 2020 | - | $281.70M(-19.0%) |
| Dec 2019 | $1.16B(+30.3%) | $347.87M(+24.9%) |
| Sep 2019 | - | $278.60M(+5.5%) |
| Jun 2019 | - | $264.19M(+22.8%) |
| Mar 2019 | - | $215.21M(-7.4%) |
| Dec 2018 | $889.58M(+50.8%) | $232.47M(-6.0%) |
| Sep 2018 | - | $247.35M(+27.9%) |
| Jun 2018 | - | $193.47M(+18.6%) |
| Mar 2018 | - | $163.11M(-9.5%) |
| Dec 2017 | $590.00M(+25.1%) | $180.15M(+28.6%) |
| Sep 2017 | - | $140.03M(+4.2%) |
| Jun 2017 | - | $134.35M(+6.4%) |
| Mar 2017 | - | $126.25M(-3.2%) |
| Dec 2016 | $471.75M(+39.9%) | $130.39M(+10.8%) |
| Sep 2016 | - | $117.72M(+19.1%) |
| Jun 2016 | - | $98.84M(-10.4%) |
| Mar 2016 | - | $110.32M(+12.3%) |
| Dec 2015 | $337.11M(+43.6%) | $98.27M(+18.2%) |
| Sep 2015 | - | $83.12M(+3.3%) |
| Jun 2015 | - | $80.47M(+16.1%) |
| Mar 2015 | - | $69.31M(+52.6%) |
| Dec 2014 | $234.78M | $45.41M(-17.4%) |
| Sep 2014 | - | $54.96M(+7.0%) |
| Jun 2014 | - | $51.37M(-80.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $259.22M(+500.0%) |
| Dec 2013 | $140.11M(+7.5%) | $43.20M(+11.7%) |
| Sep 2013 | - | $38.68M(+44.0%) |
| Jun 2013 | - | $26.86M(-2.9%) |
| Mar 2013 | - | $27.66M(-60.9%) |
| Dec 2012 | $130.29M(-5.3%) | $70.68M(+94.9%) |
| Sep 2012 | - | $36.26M(+7.2%) |
| Jun 2012 | - | $33.84M(+5.9%) |
| Mar 2012 | - | $31.95M(-8.1%) |
| Dec 2011 | $137.57M(-4.3%) | $34.76M(+2.1%) |
| Sep 2011 | - | $34.03M(-1.2%) |
| Jun 2011 | - | $34.44M(-7.4%) |
| Mar 2011 | - | $37.18M(+32.2%) |
| Dec 2010 | $143.78M(-3.3%) | $28.12M(-24.6%) |
| Sep 2010 | - | $37.30M(-9.6%) |
| Jun 2010 | - | $41.25M(+11.8%) |
| Mar 2010 | - | $36.89M(+7.2%) |
| Dec 2009 | $148.64M(+19.9%) | $34.42M(+2.9%) |
| Sep 2009 | - | $33.46M(-29.3%) |
| Jun 2009 | - | $47.30M(+43.6%) |
| Mar 2009 | - | $32.95M(-2.5%) |
| Dec 2008 | $124.00M(-13.9%) | $33.80M(+18.2%) |
| Sep 2008 | - | $28.59M(-21.9%) |
| Jun 2008 | - | $36.59M(+56.2%) |
| Mar 2008 | - | $23.43M(+41.4%) |
| Dec 2007 | $144.07M(+116.9%) | $16.57M(-76.0%) |
| Sep 2007 | - | $69.11M(+216.7%) |
| Jun 2007 | - | $21.82M(-24.4%) |
| Mar 2007 | - | $28.86M(+87.2%) |
| Dec 2006 | $66.43M(+35.1%) | $15.42M(-1.2%) |
| Sep 2006 | - | $15.61M(-2.0%) |
| Jun 2006 | - | $15.93M(+9.3%) |
| Mar 2006 | - | $14.58M(-9.1%) |
| Dec 2005 | $49.19M(+34.6%) | $16.04M(+32.7%) |
| Sep 2005 | - | $12.09M(-1.3%) |
| Jun 2005 | - | $12.25M(+48.6%) |
| Mar 2005 | - | $8.24M(-1.2%) |
| Dec 2004 | $36.54M(+77.2%) | $8.35M(+7.2%) |
| Sep 2004 | - | $7.78M(-0.7%) |
| Jun 2004 | - | $7.84M(-50.0%) |
| Mar 2004 | - | $15.68M(+778.8%) |
| Dec 2003 | $20.62M(+388.5%) | - |
| Jun 2003 | - | $1.78M(+40.9%) |
| Mar 2003 | - | $1.27M |
| Dec 2002 | $4.22M | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual total expenses?
- What is the all time high annual total expenses for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual total expenses year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual total expenses?
The current annual total expenses of ALNY is $2.43B
What is the all time high annual total expenses for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual total expenses is $2.43B
What is Alnylam Pharmaceuticals, Inc. annual total expenses year-on-year change?
Over the past year, ALNY annual total expenses has changed by +$314.66M (+14.91%)
What is Alnylam Pharmaceuticals, Inc. quarterly total expenses?
The current quarterly total expenses of ALNY is $839.97M
What is the all time high quarterly total expenses for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly total expenses is $839.97M
What is Alnylam Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
Over the past year, ALNY quarterly total expenses has changed by +$163.25M (+24.12%)